American Beacon Advisors, Inc. Amgen Inc Transaction History

American Beacon Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $399,080 - $465,855	-2,237 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $79,304 - $89,404	428 Added 23.66%	2,237 $464,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $119,389 - $134,100	719 Added 65.96%	1,809 $0
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $74,605 - $83,356	442 Added 68.21%	1,090 $0
Q2 2017 Aug 14, 2017	BUY	N/A	648	648 $112 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of American Beacon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on American Beacon Advisors, Inc. with notifications on news.